Profile on Biocurex, Inc. (BOCX)
Profile : Biocurex, Inc. (BOCX)
 |
|
Latest Newsletter Editions on BOCXTue, Mar 17, 2009 @ 01:11 pm
For those of you who've been reading the Small Cap Network newsletter for a while, you'll easily remember BioCurex Inc. (OTCBB: BOCX). For those of you who are newer, BioCurex is a company worth getting to know. For both of those groups, today's your chance to acquaint yourself with the company's recent...
Thu, Dec 20, 2007 @ 01:54 pm
The end of the year is right around the corner, and I for one am glad. We've been itching to close the books on a handful of our followings, and perhaps benefit from a tax loss (since they didn't benefit us in many other ways). At the same time, there are also a few names we want to be sure to keep...
Tue, Sep 25, 2007 @ 01:32 pm
Before I forget, I want to remind you about the Spicy Pickle's (OTCBB: SPKL) web video available simply by clicking the nearby image. From the feedback we've gotten so far, the short video has been very helpful for investors, adding any remaining details we couldn't get to in Saturday's profile. Remember...
Thu, Sep 20, 2007 @ 01:21 pm
I know I promised all of you a new trading idea on Friday. However, after thinking a little more about it, I've decided to wait until Saturday morning to send it out. I know for a lot of you a 40+ hour workweek can make it tough to read and process one more thing late in the day on a Friday. I'd rather...
Tue, Sep 18, 2007 @ 06:28 am
Well, the recent strength from BioCurex (OTCBB: BOCX) shares all makes sense now. This small cap stock flew from 46 cents to 77 cents over the last six weeks - a 67% move - on rising volume. We speculated that they were going to announce some good progress with the next phase of their cancer detection...
Click Here For More Newsletters on BOCX |
Latest Blog Entries on BOCXThu, Apr 10, 2008 @ 06:49 am
Not surprisingly, March’s retail numbers were soft…for most. Discounters like Wal-Mart (WMT) and Costco (COST) did fine, while discretionary goods saw dampened demand. The futures dropped (pre-market) on the news, though that means little to me any more. Why? I’m still mostly in a ‘bet against the open’ mode. That’s why I’m actually glad stocks [...]
Wed, Jan 9, 2008 @ 08:46 am
Color me clairvoyant, but I suspected this - or something like it - was around the corner for small cap biotech company BioCurex (BOCX). Like I said in my Top Ten Predictions for 2008 edition, the company’s deafening silence was the tip-off that something big was brewing…they have a real hot and cold streak going [...]
Fri, Sep 14, 2007 @ 12:51 pm
Like I said a few days ago (and a few days before that), it looks like something is going on with BioCurex (OTCBB: BOCX). Shares of this small-cap biotech had been up by more than 20% today…the highest levels in weeks. Volume is through the roof. And yet, no news. Based on what we know [...]
Tue, Sep 4, 2007 @ 09:44 am
We first started to talk about BioCurex (OTCBB: BOCX) and this possibility in an August 16th blog entry, which just so happens to be the pivot point for the entire market. By that time, the stock had already posted a few days worth of solid gains on stronger volume. Since then, we’ve seen some outstanding follow-through. [...]
Mon, Aug 27, 2007 @ 09:47 am
I know I keep coming back to this name, but, it is what it is. And what it is right now - as far as BioCurex (OTCBB: BOCX) is concerned - seems to be pretty good.
Just take a look at the chart. After establishing a base around 46 cents in late July and early August, [...]
|
Quote Data : BIOCUREX INC (BOCX.OB)
|
|
Insider Transactions - Balance Sheet |
+0.0100 (+8.33%)
Business Summary : Biocurex, Inc. (BOCX)
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a cancer marker known as RECAF(TM), which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.
BioCurex has signed a licensing agreement with Abbott Laboratories for BioCurex's RECAF(TM) Cancer technology as outlined in a joint press release dated March 29, 2005. The release noted that the cancer marker RECAF(TM) has emerged as a potential biomarker that may be useful in the development of new cancer diagnostics tests. Preliminary studies from the investigators at BioCurex have reported a high level of clinical sensitivity and specificity for RECAF in many of the most common cancers, including prostate, breast, colorectal, lung and others.
Disclosure
Disclaimer:
In October of 2003, TGR Group LLC was paid a fee of $25,000 and one million newly issued restricted shares by Biocurex for coverage of the Company. Under SEC Rule 144, all one million issued restricted shares have been eligible for sale into the public market since October of 2004. In addition, on March 22, 2005, TGR entered into an extended agreement with Biocurex for a fee of 25,000 newly issued restricted shares and on July 1, 2006 TGR entered into another extended agreement with Biocurex for an additional 100,000 shares of newly issued, restricted stock. On March 16, 2009, Biocurex entered into another agreement extension for an additional fee of 300,000 newly issued restricted shares.
Current Position as of 11/13/09:
160,000 Shares
Total Dollars Liquidated as of 11/13/09:
$1,051,102.49
In October of 2003, TGR Group LLC was paid a fee of $25,000 and one million newly issued restricted shares by Biocurex for coverage of the Company. Under SEC Rule 144, all one million issued restricted shares have been eligible for sale into the public market since October of 2004. In addition, on March 22, 2005, TGR entered into an extended agreement with Biocurex for a fee of 25,000 newly issued restricted shares and on July 1, 2006 TGR entered into another extended agreement with Biocurex for an additional 100,000 shares of newly issued, restricted stock. On March 16, 2009, Biocurex entered into another agreement extension for an additional fee of 300,000 newly issued restricted shares.
Current Position as of 11/13/09:
160,000 Shares
Total Dollars Liquidated as of 11/13/09:
$1,051,102.49
Recent News Headlines
Thu, 19 Nov 2009 18:02:20 Etc/GMT
Fri, 13 Nov 2009 22:30:11 Etc/GMT
Fri, 30 Oct 2009 19:41:47 Etc/GMT
Wed, 28 Oct 2009 13:30:00 Etc/GMT
Tue, 29 Sep 2009 13:30:00 Etc/GMT
RICHMOND, British Columbia -- Whispering Oaks International, Inc., d/b/a Biocurex , announced today that it is making two presentations at the annual meeting of the International Society of Oncology and Biomarkers being held this week in Amsterdam, The Netherlands.
Thu, 17 Sep 2009 13:30:00 Etc/GMT
RICHMOND, British Columbia -- Whispering Oaks International, Inc., d/b/a BioCurex announced today that it has completed a private placement financing in which it sold promissory notes in the aggregate principal amount of $450,000 and 6,428,578 shares of its common stock for an aggregate purchase price of $450,000.
Wed, 16 Sep 2009 20:16:28 Etc/GMT
Thu, 10 Sep 2009 15:23:01 Etc/GMT
Wed, 9 Sep 2009 23:51:00 Etc/GMT
Tue, 8 Sep 2009 10:01:17 Etc/GMT
Thu, 13 Aug 2009 18:40:47 Etc/GMT
Wed, 17 Jun 2009 13:30:00 Etc/GMT
Fri, 15 May 2009 10:03:04 Etc/GMT
Fri, 1 May 2009 13:00:00 Etc/GMT
Tue, 31 Mar 2009 10:02:20 Etc/GMT
Thu, 19 Feb 2009 14:00:00 Etc/GMT
Thu, 19 Feb 2009 11:00:49 Etc/GMT
Fri, 6 Feb 2009 20:57:02 Etc/GMT
Fri, 14 Nov 2008 22:31:13 Etc/GMT
